Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,231 USD | -8,33% | -17,41% | -42,40% |
Omzet 2024 * | 7,3 mln. 5,34 mln. 4,99 mln. | Omzet 2025 * | 9,12 mln. 6,68 mln. 6,24 mln. | Marktkapitalisatie | 2,09 mln. 1,53 mln. 1,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,29 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,23 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,64% |
Recentste transcriptie over InMed Pharmaceuticals Inc.
1 dag | -6,35% | ||
1 week | -17,41% | ||
Lopende maand | -34,18% | ||
1 maand | -30,57% | ||
3 maanden | -34,27% | ||
6 maanden | -64,68% | ||
Lopend jaar | -42,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,231 | -8,33% | 432 185 |
25-04-24 | 0,252 | -16,83% | 623 391 |
24-04-24 | 0,303 | +10,99% | 3 609 547 |
23-04-24 | 0,273 | -2,47% | 93 323 |
22-04-24 | 0,2799 | -3,50% | 201 283 |
uitgestelde koers Nasdaq, 26 april 2024 om 20:27 uur
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,40% | 1,53 mln. | |
-2,10% | 103 mld. | |
+0,77% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,17% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,94% | 15,52 mld. | |
+3,38% | 13,86 mld. | |
+34,27% | 12,04 mld. |